Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05131945 · ClinicalTrials.gov registry record · NA

GRAvity- Versus Wall Suction-drIven Large Volume Thoracentesis: a RAndomized Controlled Study (GRAWITAS Study)

A NA study, sponsored by M.D. Anderson Cancer Center.

Completed
Registry status
NA
Development phase
79
Enrollment target

NCT05131945: Completed NA study, sponsored by M.D. Anderson Cancer Center.

NCT05131945 is a NA study that has completed, run by M.D. Anderson Cancer Center. The registered enrollment target is 79 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (94% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist → Add completion date to calendar (.ics) →

The verdict

NCT05131945, a NA study, has completed, sponsored by M.D. Anderson Cancer Center.

COMPLETED
Registry status
NA
Development phase
79 participants
Enrollment target

Study Summary

The primary objective of this study is to compare gravity-driven versus wall suction-driven large volume therapeutic thoracentesis on the development of chest discomfort during the procedure. This study is a multicenter, single-blinded, randomized controlled trial designed to compare chest discomfort between gravity-driven and wall suction-driven therapeutic thoracentesis. Patients will be stratified by study centers, and randomly assigned to intervention and control arms; and will remain blinding to their group assignment during the procedure.

Primary Outcome

The Global Pain Score will be determined at 5 minutes post-procedure using a VAS 0-100 and represents the pain experienced by the patient during the entire procedure from the beginning to the 5-minute post-procedure assessment

Interventions

  • OTHER Standard Suction Thoracentesis
  • OTHER Gravity Thoracentesis

Trial Details

FieldValue
Enrollment Target 79 participants
Start Date 2018-12-10
Est. Completion 2024-09-10
Phase NA
M.D. Anderson Cancer Center

2,692 total trials

What the finished NCT05131945 record still lists

NCT05131945 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 79 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (94% lower).

The record links to 0 conditions, and to 2 interventions - of which Standard Suction Thoracentesis is the first listed.

NCT05131945 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT05131945 about?

NCT05131945 is a clinical study titled "GRAvity- Versus Wall Suction-drIven Large Volume Thoracentesis: a RAndomized Controlled Study (GRAWITAS Study)". The primary objective of this study is to compare gravity-driven versus wall suction-driven large volume therapeutic thoracentesis on the development of chest discomfort during the procedure. This study is a multicenter, single-blinded, randomized controlled trial designed to compare chest discomfo...

What is the current status of trial NCT05131945?

This trial is currently completed. It is a NA study. The enrollment target is 79 participants. The study started on 2018-12-10. Estimated completion is 2024-09-10.

What interventions are being tested in trial NCT05131945?

The interventions under investigation include: Standard Suction Thoracentesis (OTHER), Gravity Thoracentesis (OTHER).

Who is sponsoring clinical trial NCT05131945?

This trial is sponsored by M.D. Anderson Cancer Center, which has 2,692 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT05131945's enrollment target sits among peer trials

79 1060th of 2000 higher than 941 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT05798897 · 79 participants · Phase 1

    Safety and Preliminary Efficacy of MT-601 in Patients With Relapsed/Refractory Lymphoma

  • NCT06042439 · 79 participants · NA

    AM vs PM Exercise Training

  • NCT06223555 · 79 participants · NA

    Variability In Mixed Meal Tests: Fixed Versus Adjusted to Energy Needs Caloric Dose

  • NCT01243931 · 80 participants · NA

    Optical Coherence Tomography Guided Transepithelial Phototherapeutic Keratectomy

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT05131945, the US trial registry maintained by the National Library of Medicine. NCT05131945 (small enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.